References Chattu VK, et al
injectable dose in the evening Hair loss focus: Topical GHK-Cu serum applied to scalp daily, optionally supplemented with 1 mg/day SubQ for systemic follicle support Post-menopause skin support: 1.52 mg/day injectable is commonly used in this context, where estrogen-driven collagen decline accelerates skin thinning Combining Routes: Using topical GHK-Cu for skin alongside injectable GHK-Cu is a popular protocol among women because the two routes complement each other topical addresses surface skin quality directly, while injectable supports tissue repair and collagen signaling from within
It is sold strictly for research, not for human use
It is effective, well-tolerated, extensively studied, and produces broad-spectrum improvements that benefit nearly every patient profile
Its Time To Finally Feel Better
The safety and effectiveness of rosuvastatin as an adjunct to other LDL-C-lowering therapies to reduce LDL-C have been established pediatric patients 7 years of age and older with HoFH
